Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04865640 · ClinicalTrials.gov registry record
Clinical Validation Study for Noninvasive Cardiopulmonary Management Device
A clinical trial of Cardiopulmonary Disease, sponsored by Analog Device.
- Completed
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT04865640: Completed study of Cardiopulmonary Disease, sponsored by Analog Device.
NCT04865640 is a study of Cardiopulmonary Disease that has completed, run by Analog Device. The registered enrollment target is 40 participants, below the 524-participant average among 4 other Cardiopulmonary Disease trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04865640, a study of Cardiopulmonary Disease, has completed, sponsored by Analog Device.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The ADI At-Home CPM (Cardiopulmonary Management) System is a non-invasive device that measures and trends a variety of biological parameters. This study will be conducted as a prospective non-randomized study with two study arms/cohorts - one of healthy adult patients, one of pathologic patients who fit into the intended use population of the CPM System.
Primary Outcome
Correlation Coefficient for Respiration Rate accuracy (test device vs reference device).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Noninterventional and noninvasive
Study Locations (1)
Minnesota
- Mayo Clinic Hospital - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-11-19 |
| Est. Completion | 2021-02-16 |
What the finished NCT04865640 record still lists
NCT04865640 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 524-participant average among 4 other Cardiopulmonary Disease trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Cardiopulmonary Disease appearing as the primary indexed condition, and to 1 intervention - of which Noninterventional and noninvasive is the first listed.
NCT04865640 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04865640 about?
NCT04865640 is a clinical study titled "Clinical Validation Study for Noninvasive Cardiopulmonary Management Device". The ADI At-Home CPM (Cardiopulmonary Management) System is a non-invasive device that measures and trends a variety of biological parameters. This study will be conducted as a prospective non-randomized study with two study arms/cohorts - one of healthy adult patients, one of pathologic patients wh...
What is the current status of trial NCT04865640?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2020-11-19. Estimated completion is 2021-02-16.
What conditions does trial NCT04865640 study?
This clinical trial studies the following conditions: Cardiopulmonary Disease.
What interventions are being tested in trial NCT04865640?
The interventions under investigation include: Noninterventional and noninvasive (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04865640?
This trial is sponsored by Analog Device, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04865640 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiopulmonary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI